INDEX 705
Neuroleptic drugs, 252
Neurological exam, 155
Neuromodulators, 129–148
Neuromuscular junction, 115, 123
Neurons, 79–92
trophic support, 89–90
Neuropathic pain, 168
Neuropeptides, 130
Neuropeptide Y, 145
Neurophysin, 277
Neurosecretion, 277
Neurosteroids, 146
Neurotransmitters, 129–148
Neurotrophins, 89–91, 250
actions, 90–91
neuronal growth, 91
receptors, 90
trophic support of neurons, 89–90
Neutral fat, 24
Neutrophils, 63, 523
Newborn, hemolytic disease, 530
New brain cells, 293
NGF. See Nerve growth factor
Nicotinic actions, 135
Nicotinic acetylcholine receptors, 126
Nicotinic cholinergic receptors, 135
NIDDM. See Non-insulin-dependent diabetes
mellitus
Night terrors, 237
Nigrostriatal system, 140
Nitric oxide, 112, 563–564
NK cells. See Natural killer cells
NMDA receptors, 141
N,N-dimethyltryptamine, 137
NO synthase, 405
Nociception, 168
Nociceptive stimuli, 164
Nociceptors, 150, 167–168
Nocturia, 660
Nocturnal enuresis, 237
Nodes of Ranvier, 82
Non-insulin-dependent diabetes mellitus, 334
Non-REM sleep, 234
Nonassociative learning, 290
Noncholinergic, nonadrenergic innervation,
590
Nonclathrin/noncaveolae endocytosis, 43
Noncommunicating hydrocephalus, 571
Nonconstitutive pathway, 43
Nonconvulsive, 233
Nondeclarative memory, 290
Nonessential amino acids, 15
Nonfluent aphasias, 297
Nonionic diffusion, 6, 681
Nonspecific, 231
Nonspecific cholinesterase, 135
Nonsuppressible insulin-like activity, 318
Nonsyndromic deafness, 214
Noradrenergic neurons, 138
Norepinephrine, 138, 237, 265–266, 337
Normal arterial blood pressure, 546
Normal body temperature, 283
Normal cardiac rate, 497
Normal ECG, 494
Normal menstruation, 413
Normal sinus rhythm, NSR, 497
Nose, pain fibers in, 223
NREM sleep. See Non-REM sleep
NSILA. See Nonsuppressible insulin-like
activity
NTS. See Nucleus of solitary tract
Nuclear bag fiber, 158
Nuclear chain fiber, 158
Nuclear cholescintigraphy, 486
Nuclear factor, 76
Nuclear factor kappa B, 52
Nuclear membrane, 40
Nuclear pore complexes, 40
Nucleic acids, 454–457
Nucleolus, 40
Nucleosome, 40
Nucleus accumbens, 179
Nucleus basalis of Meynert, 293
Nucleus of solitary tract, 224
Nutrition, 463–466
caloric intake, distribution, 463–464
dietary components, 463
effect on growth, 385–386
mineral requirements, 464
vitamins, 464–466
Nutritionally essential amino acids, 15
Nyctalopia, 191
Nystagmus, 215
O
Obesity, 334–335
Objective scotomas, 198
OBP. See Odorant-binding proteins
Obstructive sleep apnea, 237
Occludin, 38
Occlusion, 123, 164
Ocular dominance columns, 194
Oculocardiac reflex, 499
Oculomotor nerve, 189
Odorant-binding proteins, 223
Odorant receptors, 219
Off-center cell, 192
Olfactory bulbs, 220–221
Olfactory cortex, 221
Olfactory epithelium, 219–220
Olfactory glomeruli, 220
Olfactory sensory neurons, 219
Olfactory thresholds, 221–222
Olfactory tubercle, 221
Oligoclonal bands, 82
Oligodendrocytes, 80
Oligomenorrhea, 423
Oliguria, 660
Olivocochlear bundle, 211
On-center cell, 192
Oncogenes, 43
Oncotic pressure, 49, 531
Open-angle glaucoma, 182
OPG. See Osteoprotegerin
Opioid peptides, 143–144
Opsin, 190
Opsonization, 64
Optical righting reflexes, 215
Optic chiasm, 184
Optic disk, 182
Optic nerve, 184
Optic pathways, lesions in, 198
Optics, 186–187
Optic tract, 184
Oral glucose tolerance test, 322
Orexin, 237
Organ of Corti, 205–206
Organelles, 31
Organum vasculosum of lamina terminalis, 276,
573
Orientation columns, 194
Orthodromic conduction, 88
Orthograde transport, 82
OSA. See Obstructive sleep apnea
Osmolal concentration of plasma, 6
Osmolarity, 5
Osmoles, 5
Osmosis, 5–6
Osmotic diuresis, 656
Osmotic pressure, 5
Osmotic pressure gradient, 548
Osmotic stimuli, 666–667
Ossicular conduction, 210
Osteoblasts, 371
Osteoclasts, 371
Osteons systems, 371
Osteopetrosis, 373
Osteoporosis, 351, 373
Osteoprotegerin, 372
Otoconia, 206, 216
Otolithic organ, 206
Otoliths, 206
Ouabain, 676
Outer hair cells, 206
Oval window, 203
Ovarian cycle, 411–412
Ovarian function, 422–423
abnormalities of, 422–423
contraception, 422
control of, 420–422
control of cycle, 421
feedback effects, 421
hypothalamic components, 420–421
menstrual abnormalities, 422–423
reflex ovulation, 421–422
Ovarian hormones, 416–420
actions, 419
breasts, 417
central nervous system, 417
chemistry, 416, 418–419
endocrine organs, 417
environmental estrogen, 418
female genitalia, 417
female secondary sex characteristics, 418
mechanism of action, 418–419
relaxin, 420
secretion, 417, 419
synthetic estrogen, 418
Ovarian hyper-stimulation syndrome, 401
Overflow incontinence, 662
Overtones, 209
OVLT. See Organum vasculosum of lamina
terminalis
Ovulation, 412
indicators of, 414–415
Oxidases, 35
Oxidation, 8
Oxidative deamination, 18
Oxidative phosphorylation, 10, 34
Oxygenation, 610
Oxygen consumption, 576–577, 645
heart, 519
Oxygen debt mechanism, 104
Oxygen delivery to tissues, 609–610
Oxygen–hemoglobin dissociation curve, 610
Oxygen transport, 609–611
Oxyhemoglobin, 523
Oxyntic cells. See Parietal cells
Oxyntomodulin, 328
Oxyphil cells, 367
Oxytocin, 277, 279, 377
effects of, 279
P
Pacemaker
abnormal, 497